THURSDAY, Jan. 31, 2019 — The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration. It can now be used to treat children aged 4 or older with asthma and adults with asthma or chronic obstructive pulmonary disease (COPD). “People […]